Gapping up
In reaction to strong earnings/guidance: LNN +8.2%, ULTA +4.2%, NEPT +3.4%, SAR +3.3%, TSM +1.7%, CSX +0.8%
Select metals/mining stocks trading higher: SBGL +3.6%, GFI +2%, HMY +1.7%, AG +1%, GG +1%, ABX +0.6%, GOLD+0.6%, GDX +0.6%, SLW +0.6%
Other news: CTRV +29.5% (reports interim data for CMX157 from its ongoing Phase 2a multiple ascending dose clinical studyg),OCUL +27.6% (Ocular Therapeutix & Regeneron (REGN) enter into a collaboration to develop sustained release formulation of Aflibercept for the treatment of Wet AMD and other serious retinal diseases), CI +2.5% (CIGNA responds to CMS's 2017 Medicare Stars Quality Ratings; no financial impact in 2016 or 2017 because these ratings apply to plans for the 2018 payment year), FCN+2.4% (its Strategic Communications segment has launched a new and enhanced Affiliate Network), ERJ +2.2% (upgraded to Buy from Neutral at Goldman), STM +1.9% (in sympathy with TSM (earnings)), EBAY +1.2% (MercadoLibre commences a 5.5 mln share underwritten public offering of common stock by selling stockholders eBay & certain subsidiaries; eBay says sale will enable it to realize a significant gain on its investment), AAMC +1% (after 30%+ move higher), WFC +0.9% (Wells Fargo Chairman, CEO John Stumpf retires; Board of Directors elects Tim Sloan CEO, Director; appoints Lead Director Stephen Sanger Chairman)
Analyst comments: ERJ +2.2% (upgraded to Buy from Neutral at Goldman), VIAB +1.5% (upgraded to Buy from Underperform at BofA/Merrill), GRUB +1.1% (upgraded to Buy from Neutral at BofA/Merril), MRK +0.8% (upgraded to Buy from Neutral at BofA/Merrill), ALK +0.8% (upgraded to Buy from Neutral at Buckingham Research)
In reaction to strong earnings/guidance: LNN +8.2%, ULTA +4.2%, NEPT +3.4%, SAR +3.3%, TSM +1.7%, CSX +0.8%
Select metals/mining stocks trading higher: SBGL +3.6%, GFI +2%, HMY +1.7%, AG +1%, GG +1%, ABX +0.6%, GOLD+0.6%, GDX +0.6%, SLW +0.6%
Other news: CTRV +29.5% (reports interim data for CMX157 from its ongoing Phase 2a multiple ascending dose clinical studyg),OCUL +27.6% (Ocular Therapeutix & Regeneron (REGN) enter into a collaboration to develop sustained release formulation of Aflibercept for the treatment of Wet AMD and other serious retinal diseases), CI +2.5% (CIGNA responds to CMS's 2017 Medicare Stars Quality Ratings; no financial impact in 2016 or 2017 because these ratings apply to plans for the 2018 payment year), FCN+2.4% (its Strategic Communications segment has launched a new and enhanced Affiliate Network), ERJ +2.2% (upgraded to Buy from Neutral at Goldman), STM +1.9% (in sympathy with TSM (earnings)), EBAY +1.2% (MercadoLibre commences a 5.5 mln share underwritten public offering of common stock by selling stockholders eBay & certain subsidiaries; eBay says sale will enable it to realize a significant gain on its investment), AAMC +1% (after 30%+ move higher), WFC +0.9% (Wells Fargo Chairman, CEO John Stumpf retires; Board of Directors elects Tim Sloan CEO, Director; appoints Lead Director Stephen Sanger Chairman)
Analyst comments: ERJ +2.2% (upgraded to Buy from Neutral at Goldman), VIAB +1.5% (upgraded to Buy from Underperform at BofA/Merrill), GRUB +1.1% (upgraded to Buy from Neutral at BofA/Merril), MRK +0.8% (upgraded to Buy from Neutral at BofA/Merrill), ALK +0.8% (upgraded to Buy from Neutral at Buckingham Research)